Skip to main content
. 2021 Apr 21;11:632094. doi: 10.3389/fonc.2021.632094

Figure 3.

Figure 3

Survival curves of pediatric AML patients according to WT1 mutations and hematopoietic stem cell transplantation (HSCT) status. Probability of EFS (A) and OS (B) for patients with WT1 mutations according to HSCT status, respectively. Probability of EFS (C) and OS (D) for patients with WT1 mutations and FLT3/ITD positive according to HSCT status, respectively.